“While white addicts receive treatment, drug counseling, and a lenient criminal justice system, there are Black people still behind bars because of mandatory minimums, three-strikes laws, and disparate drug sentencing.”
Throughout my career as a cannabis journalist, I’ve kept silent about my sobriety. Finding freelance gigs is hard enough without the added burden of having to be that guy. Besides, if I learned anything from active addiction, it was how to lie at my job.
Dr. Shover, a postdoctoral research fellow at Stanford University worked with fellow researchers Corey Davis, Sanford Gordon, and Keith Humphreys to buck a cannabis industry pearl of conventional wisdom; the oft-cited, often-sloganeered study by Marcus Bachhuber that found a positive correlation between medical cannabis states and a decrease in opioid overdose deaths from 1999-2010.
In a somewhat uniquely American way, opioid use disorder has become a marketing boon for the emerging cannabis industry. Advocates and industrialists alike have focus-grouped America’s deadliest epidemic into a modern-day Pepsi Challenge; a double-blind, peer-reviewed taste test where four-out-of-five addicts prefer medical marijuana.